Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123747923 | 12374792 | 3 | F | 20160719 | 20160517 | 20160729 | EXP | US-PFIZER INC-2016249743 | PFIZER | 73.00 | YR | M | Y | 82.54000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123747923 | 12374792 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | N | 0069-0550-38 | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 123747923 | 12374792 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 3 | C | VITAMIN C | ASCORBIC ACID | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 4 | C | GLUCOSAMINE CHONDROITIN | CHONDROITIN SULFATE (BOVINE)GLUCOSAMINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 5 | C | NIACIN. | NIACIN | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 8 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 9 | C | PROBIOTICS | PROBIOTICS NOS | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 11 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 12 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 13 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | 0 | |||||||||||
| 123747923 | 12374792 | 14 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 123747923 | 12374792 | 15 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123747923 | 12374792 | 1 | Renal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123747923 | 12374792 | HO |
| 123747923 | 12374792 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123747923 | 12374792 | Asthenia | |
| 123747923 | 12374792 | Condition aggravated | |
| 123747923 | 12374792 | Dehydration | |
| 123747923 | 12374792 | Dyspnoea | |
| 123747923 | 12374792 | Lung neoplasm malignant | |
| 123747923 | 12374792 | Second primary malignancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123747923 | 12374792 | 1 | 20160415 | 20160503 | 0 | |
| 123747923 | 12374792 | 4 | 201605 | 0 | ||
| 123747923 | 12374792 | 5 | 201605 | 0 | ||
| 123747923 | 12374792 | 6 | 201605 | 0 | ||
| 123747923 | 12374792 | 7 | 201605 | 0 | ||
| 123747923 | 12374792 | 10 | 201605 | 0 | ||
| 123747923 | 12374792 | 13 | 201605 | 0 |